Key Highlights:

  • Commerce and Industry Minister Piyush Goyal began a four-day Japan visit (August 24-27) covering Tokyo, Nagoya and Osaka.
  • India's largest-ever business delegation to Japan, comprising more than 200 business representatives, is accompanying the Minister.
  • Goyal opened his engagements with Sumitomo Corporation President & CEO Shingo Ueno, focusing on energy transformation, mobility and industrial infrastructure.
  • Met Meiji Seika Pharma President Toshiaki Nagasato to discuss expanding Japanese manufacturing and R&D footprint in India's pharma sector.
  • Roundtable planned with Keidanren, the apex body representing over 1,500 leading Japanese companies; dedicated sessions on semiconductors, AI, start-ups and FIIs.

Commerce and Industry Minister Piyush Goyal kicked off his high-stakes official visit to Japan on Monday, opening the door on what officials are describing as one of the most ambitious bilateral business outreaches in recent years. Landing in Tokyo, Goyal is leading India's largest-ever business delegation to Japan — comprising more than 200 business representatives — and will travel to Tokyo, Nagoya and Osaka between August 24 and 27. The delegation spans a strategic mix of sectors: manufacturing, semiconductors, clean energy, steel, automotive, financial services, healthcare and start-ups.

First Stop: Sumitomo Corporation

Goyal began his engagements in Tokyo with a meeting with Shingo Ueno, President and CEO of Sumitomo Corporation. "Began my engagements in Tokyo with an excellent meeting with Shingo Ueno, President and CEO at Sumitomo Corporation. We discussed opportunities to deepen the company's engagement with India across energy transformation, mobility and industrial infrastructure," the Minister posted on X. He added that India's investment-led growth and expanding manufacturing ecosystem offer immense opportunities for greater collaboration and would further strengthen the India-Japan economic partnership.

The Pharma Push: Meeting Meiji Seika

The Minister also met Toshiaki Nagasato, President and Representative Director of Meiji Seika Pharma Co., Ltd., where the conversation focused on strengthening India-Japan cooperation in the pharmaceutical sector and pathways to expand the company's manufacturing and R&D footprint in India. "India's pharmaceutical ecosystem offers significant opportunities for our Japanese partners to scale and achieve long-term growth," Goyal said, positioning India's pharma capabilities as a natural extension for Japanese healthcare majors seeking scale.

Delegation Composition: A Full-Spectrum Play

The composition of the 200-plus delegation signals New Delhi's intent to move beyond legacy sectors like automotive and infrastructure — where Japan has been a long-standing partner — and into the sunrise economy pillars of chips, clean energy and start-ups. The delegation represents a cross-section of India Inc., and is designed to unlock B2B linkages that go beyond ministerial handshakes.

Keidanren Roundtable: The Big Room in Tokyo

A key highlight of the visit will be Goyal's roundtable with Keidanren, the Japan Business Federation, which represents over 1,500 leading Japanese companies. The forum is arguably the single most important business audience for any visiting Indian delegation, and offers a direct channel to Japanese conglomerates weighing their next round of overseas capital allocation.

Semiconductors, AI, Start-ups: The New Agenda

Beyond legacy interactions, dedicated sessions have been planned on semiconductors and artificial intelligence, start-ups, and engagement with foreign institutional investors. This reflects India's push to be recognised not just as a manufacturing base, but as a destination for high-value innovation capital. The chip and AI sessions, in particular, come at a moment when Japan is reshaping its semiconductor strategy and looking for reliable partners in Asia.

Why It Matters: Special Strategic and Global Partnership Gets a Reset

The visit reflects the scale of ambition both nations bring to their Special Strategic and Global Partnership, and comes at a time when both sides are looking to significantly deepen trade and investment ties. For India, Japan represents a source of long-term, patient capital and high-quality technology transfer. For Japan, India offers scale, demographic depth and a stable growth market at a time when Japanese firms are actively diversifying their Asia footprint.

Industry Impact: What to Watch

Expect the coming days to yield sector-specific MoUs and investment announcements, particularly in clean energy, mobility, semiconductors and pharma. Japanese conglomerates already invested in India — across autos, steel, financial services and consumer goods — are likely to explore fresh commitments, while newer entrants may use the visit to signal India-market intent. The start-up track, meanwhile, could open a new capital pipeline from Japanese corporate venture arms into India's tech ecosystem.

Osaka Finale: An Investors Roadshow

The visit will conclude in Osaka with an Investors and Business Roadshow, along with meetings with leading Japanese companies across electronics, industrial and consumer sectors. The Osaka leg is designed to showcase opportunities across India's manufacturing, clean energy and consumer markets — extending the engagement beyond Tokyo's corporate towers into Japan's industrial heartland.

The Bigger Picture

Goyal's Japan mission is more than a diplomatic itinerary. It is a signal of intent: that India is willing to bring its biggest business voices to the table, and expects Japan to reciprocate with capital and technology at scale. If even a portion of the delegation's ambitions translate into signed deals over the next quarter, the India-Japan economic partnership could be entering its most consequential phase in years.